Atlas Trials

Single and Multiple Ascending Oral Doses of Avenanthramide

Clinical trial NCT06101784 · COMPLETED

Trial details

NCT number
NCT06101784
Sponsor
Montreal Heart Institute
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Inflammation
Start date
2023-12-09
Primary completion
2025-06-16
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.